Literature DB >> 24630966

MicroRNA-145: a promising biomarker for hepatocellular carcinoma (HCC).

Xianchun Duan1, Jianpeng Hu2, Yongzhong Wang1, Jiarong Gao1, Daiyin Peng2, Lunzhu Xia3.   

Abstract

It has been demonstrated that microRNA-145 (miR-145) is downregulated in patients with hepatocellular carcinoma (HCC) compared with healthy controls. The mechanisms for miR-145 in HCC will become potential in future researches.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; miR-145

Mesh：

Substances：

Year:  2014        PMID： 24630966     DOI： 10.1016/j.gene.2014.03.018

Source DB:  PubMed          Journal:  Gene        ISSN： 0378-1119            Impact factor:   3.688


  11 in total

Review 1.  Significant biomarkers for the management of hepatocellular carcinoma.

Authors:  Yasuteru Kondo; Osamu Kimura; Tooru Shimosegawa
Journal:  Clin J Gastroenterol       Date:  2015-04-09

2.  Inhibition of SW620 human colon cancer cells by upregulating miRNA-145.

Authors:  Chen Li; Na Xu; Yu-Qiang Li; Yu Wang; Zhi-Tu Zhu
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

3.  MicroRNA-337 regulates the PI3K/AKT and Wnt/β-catenin signaling pathways to inhibit hepatocellular carcinoma progression by targeting high-mobility group AT-hook 2.

Authors:  Hongzhang Cui; Ruijin Song; Ju Wu; Wei Wang; Xi Chen; Jiajun Yin
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

4.  miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7.

Authors:  Ying Ma; Xing-guo She; Ying-zi Ming; Qi-quan Wan
Journal:  Tumour Biol       Date:  2014-07-30

5.  Circulating microRNAs for early detection of hepatitis B-related hepatocellular carcinoma.

Authors:  Simonetta Bandiera; Thomas F Baumert; Mirjam B Zeisel
Journal:  Hepatobiliary Surg Nutr       Date:  2016-06       Impact factor: 8.265

6.  MicroRNA-592 targets IGF-1R to suppress cellular proliferation, migration and invasion in hepatocellular carcinoma.

Authors:  Wenyao Wang; Hongfei Zhang; Mao Tang; Longlong Liu; Zhengfang Zhou; Shaojun Zhang; Lichao Wang
Journal:  Oncol Lett       Date:  2017-03-24       Impact factor: 2.967

7.  The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2.

Authors:  Chen Li; Lu Lu; Bing Feng; Kai Zhang; Siqi Han; Daorong Hou; Longbang Chen; Xiaoyuan Chu; Rui Wang
Journal:  Sci Rep       Date:  2017-07-05       Impact factor: 4.379

8.  miR-145 Inhibits Th9 Cell Differentiation by Suppressing Activation of the PI3K/Akt/mTOR/p70S6K/HIF-1α Pathway in Malignant Ascites from Liver Cancer.

Authors:  You-Yi Huang; Hai-Xing Jiang; Qiu-Yue Shi; Xin Qiu; Xi Wei; Xiang-Lian Zhang; Shan-Yu Qin
Journal:  Onco Targets Ther       Date:  2020-05-05       Impact factor: 4.147

9.  Targeting Epidermal Growth Factor Receptor by MiRNA-145 Inhibits Cell Growth and Sensitizes NSCLC Cells to Erlotinib.

Authors:  Jamal Amri; Neda Molaee; Maryam Baazm; Hadi Karami
Journal:  Asian Pac J Cancer Prev       Date:  2019-09-01

10.  Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma.

Authors:  Ji Yu Wang; Meng Fang; Alex Boye; Chao Wu; Jia Jun Wu; Ying Ma; Shu Hou; Yue Kan; Yan Yang
Journal:  Oncotarget       Date:  2017-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.